Cipla Limited has submitted its quarterly certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 31st March, 2026. The pharmaceutical company filed this regulatory compliance document with multiple stock exchanges on 9th April, 2026.

Regulatory Filing Details

The certificate was submitted to three exchanges where Cipla's securities are listed:

Rajendra Chopra, Company Secretary of Cipla Limited, signed and submitted the certificate on behalf of the company. The document was digitally signed on 9th April, 2026 at 17:24:19 +05'30'.

Certificate Confirmation by Registrar

KFin Technologies Limited, serving as Cipla's Registrar and Share Transfer Agent with SEBI Registration No. INR000000221, issued the confirmation certificate dated 1st April, 2026. The certificate covers the period from 1st January, 2026 to 31st March, 2026.

Compliance Confirmations

KFin Technologies Limited confirmed adherence to the following regulatory requirements during the quarter:

• Confirmed demat requests within 15 days of receipt from depository participants
• Verified that securities in certificates were listed on appropriate stock exchanges
• Mutilated and cancelled security certificates after due verification
• Substituted depository names in the register of members for approved demat requests

Rajitha Cholleti, Vice President at KFin Technologies Limited, signed the confirmation certificate on behalf of the registrar. The certificate demonstrates Cipla's ongoing compliance with SEBI regulations governing depositories and participants in the securities market.

Corporate Information

KFin Technologies Limited operates from its operations centre in Hyderabad's Financial District and maintains its registered office in Mumbai. The company holds CIN: L72400MH2017PLC444072 and continues to serve as Cipla's registrar for share transfer and related services.

Cipla Ltd. recorded a significant block trade on the National Stock Exchange (NSE) worth ₹18.49 crores, highlighting substantial institutional activity in the pharmaceutical stock.

Block Trade Details

The transaction involved the exchange of approximately 150,461 shares at a price of ₹1228.80 per share. Block trades represent large-volume transactions that are typically executed outside the regular market mechanism to minimize market impact.

Market Significance

Block trades often indicate strategic portfolio movements by institutional investors, fund managers, or large stakeholders. These transactions are executed when substantial volumes need to be traded without causing significant price volatility in the regular market.

Such institutional activity in Cipla's stock reflects the continued interest of large investors in the pharmaceutical sector. The execution at ₹1228.80 per share represents the agreed-upon price between the participating parties for this substantial transaction.